Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NYSE:SNY)

38.67
Delayed Data
As of 4:02pm ET
 -0.38 / -0.97%
Today’s Change
37.41
Today|||52-Week Range
51.88
-9.33%
Year-to-Date
Cramer: It's a Presidential Campaign, So Let the Corporate Bashing Begin
7:03pm / TheStreet.com - Paid Partner Content
Biotechs Rally on Pfizer/Medivation Deal
Aug 22 / TheStreet.com - Paid Partner Content
Mylan Falls After Being Called Out on Price Increases -- Should You Worry?
4:09pm / TheStreet.com - Paid Partner Content
Sanofi Diabetes Combination Drug FDA Action Date Extended
Aug 22 / Zacks.com - Paid Partner Content
Dear Pfizer, Stop Overpaying for Acquisitions!
3:45pm / MotleyFool.com - Paid Partner Content
Pfizer to Buy Medivation for $14B, Boost Cancer Franchise
Aug 22 / Zacks.com - Paid Partner Content
Mylan (MYL) Draws Flak for Over Pricing EpiPen, Stock Down
8:19am / Zacks.com - Paid Partner Content
Bret Jensen Reporting for Duty
Aug 22 / TheStreet.com - Paid Partner Content
Regeneron Stock Up on BARDA Deal for MERS Antibodies
Aug 23 / Zacks.com - Paid Partner Content
5 Things You Must Know Before the Market Opens Monday
Aug 22 / TheStreet.com - Paid Partner Content
What Pfizer Gets in Its $14 Billion Medivation Deal
Aug 23 / MotleyFool.com - Paid Partner Content
Pfizer-Medivation Close to Signing $14B Acquisition Deal?
Aug 22 / Zacks.com - Paid Partner Content
Pfizer to Buy Medivation for $14B, Boost Cancer Franchise (revised)
Aug 23 / Zacks.com - Paid Partner Content
3 Reasons Medivation Is the Juiciest Target in Biotech
Aug 21 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Bought Medivation (MDVN), but is it a Good Deal?
Aug 22 / Zacks.com - Paid Partner Content
Why Portola Pharmaceuticals Inc Is Plunging Today
Aug 18 / MotleyFool.com - Paid Partner Content
Pfizer-Medivation Close to Signing $14B Acquisition Deal? (revised)
Aug 22 / Zacks.com - Paid Partner Content
What CVS and Express Scripts' Drug Exclusion Lists Means for Your Portfolio
Aug 15 / TheStreet.com - Paid Partner Content
Medivation Scores Premium in Sale to Pfizer
Aug 22 / TheStreet.com - Paid Partner Content
Immune Design (IMDZ) Posts Wider-than-Expected Q2 Loss
Aug 10 / Zacks.com - Paid Partner Content
3 Stocks We Wouldn't Touch With a 10-Foot Pole
Aug 22 / MotleyFool.com - Paid Partner Content
Regeneron Pharmaceuticals Inc.'s Q2 Earnings -- It's Still All About Eylea, but Not f...
Aug 10 / MotleyFool.com - Paid Partner Content
ETFs in Focus on Pfizer's Medivation Acquisition
Aug 22 / Zacks.com - Paid Partner Content
BioMarin (BMRN) Posts Narrower Q2 Loss, Sales View Upped
Aug 05 / Zacks.com - Paid Partner Content
Medivation's Shares Soar on Confirmation of a Pfizer Buyout
Aug 22 / MotleyFool.com - Paid Partner Content